BioRestorative Therapies (BRTX) Total Debt (2010 - 2021)
BioRestorative Therapies' (BRTX) quarterly Total Debt came in at $250000.0 in Q4 2021, down 94.15% YoY from $4.3 million in Q4 2020, and little changed on a QoQ basis from $250000.0 in Q3 2021.
BioRestorative Therapies (BRTX) Total Debt (2010 - 2021) Analysis & Trends
BioRestorative Therapies (BRTX) has 12 years of Total Debt data on file, last reported at $250000.0 in Q4 2021.
- Quarterly Total Debt fell 94.15% year-over-year to $250000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $250000.0 (down 94.15% YoY) and the FY2021 annual result came in at $250000.0, down 94.15% from the prior year.
- Total Debt was little changed at $250000.0 in Q4 2021, from $250000.0 in the prior quarter.
- In the past five years, Total Debt ranged from a high of $5.7 million in Q2 2019 to a low of $25000.0 in Q4 2019.
- A 5-year average of $2.6 million and a median of $3.3 million in 2017 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2019 — Total Debt tumbled 96.38% — and 2020, when it jumped 16980.93%.
- Tracing BRTX's Total Debt over 5 years: stood at $3.7 million in 2017, then slumped by 85.69% to $523894.0 in 2018, then sank by 95.23% to $25000.0 in 2019, then jumped by 16980.93% to $4.3 million in 2020, then plunged by 94.15% to $250000.0 in 2021.
- The last three Total Debt figures came in at $250000.0 (Q4 2021), $250000.0 (Q3 2021), and $5.1 million (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | BioRestorative Therapies | 2.00 Mn | -953,752.60 | 17,964.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 250,000.00 |
| Sep 30, 2021 | 250,000.00 |
| Jun 30, 2021 | 5.06 Mn |
| Mar 31, 2021 | 4.49 Mn |
| Dec 31, 2020 | 4.27 Mn |
| Mar 31, 2020 | 4.20 Mn |
| Dec 31, 2019 | 25,000.00 |
| Sep 30, 2019 | 157,143.00 |
| Jun 30, 2019 | 5.70 Mn |
| Mar 31, 2019 | 4.00 Mn |
| Dec 31, 2018 | 523,894.00 |
| Sep 30, 2018 | 4.34 Mn |
| Jun 30, 2018 | 368,718.00 |
| Mar 31, 2018 | 3.78 Mn |
| Dec 31, 2017 | 3.66 Mn |
| Sep 30, 2017 | 2.93 Mn |
| Jun 30, 2017 | 120,120.00 |
| Mar 31, 2017 | 2.08 Mn |
| Dec 31, 2016 | 2.16 Mn |
| Jun 30, 2016 | 514,841.00 |